THE CHEMOURS COMPANY

CC
Delayed Quote. Delayed  - 11/24 04:10:00 pm
25.6USD +8.15%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 5 5264 864
EBITDA1 1 020850
Operating profit (EBIT)1 709526
Operating Margin 12,8%10,8%
Pre-Tax Profit (EBT) --
Net income -52,0-
Net margin -0,94%-
EPS2 -0,321,80
Dividend per Share2 1,001,01
Last update 02/13/202011/24/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 3 2173 122
Net Cash position1 --
Leverage (Debt / EBITDA) 3,15x3,67x
Free Cash Flow1 169306
ROE (Net Profit / Equities) 49,2%40,6%
Shareholders' equity -106-
ROA (Net Profit / Asset) 5,73%4,14%
Assets -907-
Book Value Per Share2 4,214,63
Cash Flow per Share 3,94-
Capex1 481273
Capex / Sales 8,70%5,61%
Last update 02/13/2020-
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 4 211 M $ -
Entreprise Value (EV) 7 333 M $ 7 204 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 14,2x 9,85x
Capitalization / Revenue 0,87x 0,79x
EV / Revenue 1,51x 1,37x
EV / EBITDA 8,63x 7,05x
Yield (DPS / Price) 3,95% 4,15%
Price to book (Price / BVPS) 5,53x 4,44x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 10,8% 13,3%
Operating Leverage (Delta EBIT / Delta Sales) -2,15x 3,53x
Net Margin (Net Profit / Revenue) 0 0
ROA (Net Profit / Asset) 4,14% 6,46%
ROE (Net Profit / Equities) 40,6% 47,0%
Rate of Dividend 56,2% 40,8%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   5,61% 6,92%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 0 0
Financial Leverage (Net Debt / EBITDA) 3,67x 2,88x
Price Earning Ratio
EPS & Dividend